Arrow Mark Colorado Holdings LLC Nuvalent, Inc. Transaction History
Arrow Mark Colorado Holdings LLC
- $8.04 Billion
- Q1 2024
A detailed history of Arrow Mark Colorado Holdings LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 140,959 shares of NUVL stock, worth $10.3 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
140,959
Previous 199,051
29.18%
Holding current value
$10.3 Million
Previous $14.6 Million
27.74%
% of portfolio
0.13%
Previous 0.17%
Shares
5 transactions
Others Institutions Holding NUVL
# of Institutions
183Shares Held
54.4MCall Options Held
838KPut Options Held
116K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.46 Billion31.01% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.18MShares$305 Million11.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$249 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.78MShares$203 Million4.39% of portfolio
-
Black Rock Inc. New York, NY2.71MShares$198 Million0.0% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.14B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...